Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...

Russell Crowe previously discussed how he lost 55 pounds with the help of the Ways2Well program. Here's what to know.

Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

UK health experts issued fresh warnings about the 'ongoing risk of infection' associated with non-sterile wet wipes contaminated with Burkholderia stabilis.

A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.

Investigators sought to determine if the gemcitabine intravesical system plus intravenous cetrelimab could improve survival for patients with muscle-invasive bladder cancer who did not receive radical ...

Yasmin Neves thought she was the fittest and healthiest shape of her life when she was struck down with strange mystery ...

NEXT WEEK ARE NOW GOING TO BE DELAYED. I.V. FLUID IS LIKE A LIFELINE TO PATIENTS. THAT LIFELINE IS IN SHORT SUPPLY AND NOW IMPACTING PATIENTS WHO HAVE NON-EMERGENCY SURGERIES SCHEDULED AT MASS.

Affinia Therapeutics has received the US Food and Drug Administration (FDA) fast track designation (FTD) for AFTX-201, a genetic medicine under investigation for treating Bcl-2-associated athanogene 3 ...

For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment ...

The agreement will see Esperion, via a subsidiary, purchase all outstanding stock of Corstasis for an upfront cash payment of ...